Literature DB >> 2470498

Structural analysis of the DF3 human breast carcinoma-associated protein.

M Abe1, D Kufe.   

Abstract

The monoclonal antibody (MAb) DF3 reacts with a high molecular weight glycoprotein detectable in human breast carcinomas and human milk. The present studies have analyzed the structure of DF3 protein produced by human BT-20 and MCF-7 breast carcinoma cells. The size of the DF3 core protein was determined by glycosidase digestion of purified DF3 glycoprotein and by immunoprecipitation after [3H]proline labeling. A core protein size of approximately Mr 160,000 was obtained for DF3 protein in BT-20 cells. In contrast, two DF3 proteins of approximately Mr 160,000 and 230,000 were detectable in MCF-7 cells. Amino acid analysis indicated that DF3 antigen from these cells is relatively rich in threonine, serine, proline, glycine, and alanine. The results also demonstrate that the DF3 epitope resides on the core protein, although reactivity with MAb DF3 was affected by the presence of carbohydrate. Finally, using synthetic peptides, we demonstrate that the DF3 epitope is present within the 20 amino acids encoded by the tandem repeat recently identified from our sequence analysis of a DF3 complimentary DNA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2470498

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  13 in total

1.  Biochemical analysis of a bladder-cancer-associated mucin: structural features and epitope characterization.

Authors:  A Bergeron; H LaRue; Y Fradet
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

2.  MUC1/A and MUC1/B splice variants differentially regulate inflammatory cytokine expression.

Authors:  Yoannis Imbert-Fernandez; Brandie N Radde; Yun Teng; William W Young; Chuan Hu; Carolyn M Klinge
Journal:  Exp Eye Res       Date:  2011-08-16       Impact factor: 3.467

Review 3.  Adenoviral vectors for prodrug activation-based gene therapy for cancer.

Authors:  Joshua C Doloff; David J Waxman
Journal:  Anticancer Agents Med Chem       Date:  2014-01       Impact factor: 2.505

4.  Circulating tumor-associated antigens detected by monoclonal antibodies against the polypeptide core of mucin--comparison of antigen MUSE11 with CA15-3.

Authors:  Y Hinoda; H Kakiuchi; N Nakagawa; Y Ohe; T Sugiyama; M Tsujisaki; K Imai; A Yachi
Journal:  Gastroenterol Jpn       Date:  1992-06

5.  Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1-positive carcinoma cells.

Authors:  Dongshu Chen; Jianchuan Xia; Yasuhiro Tanaka; Hongsong Chen; Shigeo Koido; Oliver Wernet; Pinku Mukherjee; Sandra J Gendler; Donald Kufe; Jianlin Gong
Journal:  Immunology       Date:  2003-06       Impact factor: 7.397

6.  Characterization of cis-acting elements regulating transcription of the human DF3 breast carcinoma-associated antigen (MUC1) gene.

Authors:  M Abe; D Kufe
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

Review 7.  MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches.

Authors:  D W Kufe
Journal:  Oncogene       Date:  2012-05-14       Impact factor: 9.867

Review 8.  Functional targeting of the MUC1 oncogene in human cancers.

Authors:  Donald W Kufe
Journal:  Cancer Biol Ther       Date:  2009-07-27       Impact factor: 4.742

9.  Proteomic comparison of mcf-7 tumoursphere and monolayer cultures.

Authors:  Brian J Morrison; Marcus L Hastie; Yadveer S Grewal; Zara C Bruce; Chris Schmidt; Brent A Reynolds; Jeffrey J Gorman; J Alejandro Lopez
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

10.  The MUC1 extracellular domain subunit is found in nuclear speckles and associates with spliceosomes.

Authors:  Priyadarsini Kumar; Priyadarsina Kumar; Louise Lindberg; Twanda L Thirkill; Jennifer W Ji; Lindsay Martsching; Gordon C Douglas
Journal:  PLoS One       Date:  2012-08-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.